While Nufarm's share price has seen a modest 10% recovery in recent months, investors who bought three years ago are still sitting on heavy losses, with the stock down 60% over that period. The agricultural chemical company's declining revenue and lack of profitability continue to weigh on market sentiment.
Newly unsealed correspondence contradicts CEO's prior statements, sparking investor concern amid broader challenges for the electric vehicle maker.
January 2026 saw dramatic swings across commodity markets, with precious metals soaring to record highs before a sharp correction, while energy commodities rallied on strong winter demand. The month underscored the sector's inherent volatility amid shifting seasonal and macroeconomic forces.
CNBC's Jim Cramer issues a stark warning on Bitcoin's volatility, predicting a key support level while questioning MicroStrategy's Michael Saylor. Amid a sharp sell-off, Saylor's firm continues its aggressive accumulation strategy.
Shares of Coterra Energy (CTRA) have surged recently, prompting investors to weigh its strong financials and long-term returns against potential risks in the volatile energy sector. With the stock trading below analyst targets, the question of genuine value versus priced-in optimism takes center stage.
A surge of newly unlocked tokens from major projects including Hyperliquid, XDC Network, and Berachain is set to hit the market in the first week of February 2026, potentially testing investor sentiment and liquidity.
Crude oil and gasoline futures tumbled sharply on Thursday, pressured by a surging U.S. dollar and signs of diplomatic progress between the U.S. and Iran. The sell-off erases recent geopolitical risk premiums, with increased supply from Venezuela adding further downward momentum.
IAMGOLD (TSX:IMG) has reignited drilling at its Anik joint venture in Québec and issued updated production guidance, signaling accelerating operational momentum. The moves come as the gold miner's shares, despite recent volatility, have delivered staggering multi-year returns, highlighting a potential valuation gap.
Vulcan Materials shares have more than doubled over five years, but new analysis suggests the construction aggregate giant's stock may now be trading at a premium to its intrinsic value, raising questions for potential investors.
While Wall Street chases the latest weight-loss drug headlines, Novo Nordisk's recent launch of an oral GLP-1 therapy and its entrenched insulin business present a compelling value proposition for long-term investors.
Crude oil futures fell sharply on Monday, erasing recent gains tied to Middle East tensions, as the prospect of renewed diplomatic talks between Washington and Tehran eased fears of a major supply disruption.
While analysts project another year of strong gains for the S&P 500, two key long-term valuation metrics are flashing red, reaching levels historically associated with major market downturns.
GameStop shares rallied over 6% after CEO Ryan Cohen outlined a bold vision to transform the struggling retailer into a consumer sector powerhouse through strategic M&A, leveraging its substantial cash reserves.
STAAR Surgical's stock fell sharply after the ophthalmic device maker announced the appointment of interim co-CEOs, fueling investor uncertainty following the CEO's recent departure and a failed takeover attempt.
Shares of Columbia Financial (CLBK) rallied sharply after the community bank announced a definitive agreement to acquire Northfield Bancorp, a move set to create New Jersey's third-largest regional bank and significantly boost future earnings.
A wave of experienced investors on Reddit are sharing the pivotal financial and psychological benchmarks that convinced them to leave their W2 jobs behind. The consensus? It's less about net worth and more about sustainable cash flow, strategic planning, and navigating hidden hurdles like financing and healthcare.
Despite trailing the S&P 500 and retail sector ETFs over the past year, Kroger retains a 'Moderate Buy' consensus from analysts, who see potential upside driven by product expansion and steady earnings—even as mixed quarterly results weigh on near-term sentiment.
An analysis of the most-held stocks on the Robinhood platform reveals where the retail investing crowd is placing its bets, with two tech giants emerging as particularly compelling long-term investments.
Broadcom (AVGO) shares present a complex picture for investors, with recent pullbacks contrasting sharply with stellar multi-year gains. As the chip giant navigates its AI-driven growth story, analysts debate whether the current price still offers value or if risks are mounting.
Merck & Co. is set to report fourth-quarter 2025 results before the bell on Tuesday, with Wall Street anticipating steady growth. The pharmaceutical giant's shares have climbed 13% over the past year, outpacing the broader healthcare sector. All eyes will be on Keytruda's sales trajectory and management's guidance for the year ahead.
